RxDoctor Payments Data

Nancy Bender Hausman

Sleep Medicine · Grand Rapids, MINPI 1366460172

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.1% of the total across 139 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 46.8% of the total.

$3,543in general payments, 2019–2025

Across 139 payments — averaging $25.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Jazz Pharmaceuticals Inc.$2K
  • Harmony Biosciences LLC$669
  • Axsome Therapeutics, Inc.$443
  • Avadel CNS Pharmaceuticals, LLC$235
  • ZOLL Respicardia, Inc.$133
  • Cadwell Industries, Inc$133
  • plus $273 from 6 others

What the payments were for

  • Food & beverage$3,22791%
  • Education$3169%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,543 in reported general payments places this provider in the 75th percentile of 78 sleep medicine providers in Michigan.

See all sleep medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$27,979
Medicare patients
203
Services billed
254

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XywavSodium,calcium,mag,pot Oxybate35$686,754
Sodium Oxybate12$227,255
Dextroamphetamine Sulfate ErDextroamphetamine Sulfate24$5,468
Ramelteon24$2,162
Modafinil26$2,077
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine63$1,946
Dextroamphetamine Sulfate21$1,558
Armodafinil13$1,135
Triazolam17$861
Quetiapine Fumarate24$642
Zolpidem Tartrate ErZolpidem Tartrate26$489
Gabapentin34$401
Mirtazapine22$401
Clonazepam65$399
Zolpidem Tartrate76$320

Paid to pharmacies, not to this prescriber.

Other sleep medicine in Grand Rapids

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →